Frontlight ResearchEarly access
Taking peoplePhase 4
Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled, superiority trial
Key facts
- Who runs it
- Stichting Radboud University Medical Center
- Where
- Netherlands10 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 76 people, planned
- Started
- 2 May 2024
- Planned end
- 1 Jul 2025
- Type of study
- Interventional
- Record updated
- 31 March 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Confirmed chronic pancreatitis
- Abdominal pain typical for chronic pancreatitis (i.e. dull epigastric pain), NRS ≥ 3, ≥ 3 days/week for two weeks
Who cannot take part
- Endoscopic or surgical intervention < 3 months prior to inclusion
- Expected endoscopic or surgical intervention for CP within trial duration (6 weeks)
- Start of amitriptyline, pregabalin or gabapentin less than 6 weeks prior to inclusion
- Usage of more than 90 morphine milligram equivalents per day
- Active use of metamizole at inclusion
- Contra-indications to metamizole
- Pancreatic carcinoma
This trial is currently available in Netherlands.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To study if adding metamizole three times daily at a dosage of 1000mg to the current analgesic therapy effectively reduce pain in patients with painful chronic pancreatitis, with time since diagnosis of less than 3 years
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled trial.
- Record updated
- 31 March 2025